Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment. | Front Immunol | 2023 | 37033960 | PubTator, text mining | PubMed |
| Chalcone: A potential scaffold for NLRP3 inflammasome inhibitors. | Eur J Med Chem Rep | 2023 | 37033416 | PubTator, text mining | PubMed |
| Porphyromonas gingivalis induction of TLR2 association with Vinculin enables PI3K activation and immune evasion. | PLoS Pathog | 2023 | 37023213 | PubTator, text mining | PubMed |
| Analysis of the ERK Pathway Cysteinome for Targeted Covalent Inhibition of RAF and MEK Kinases. | J Chem Inf Model | 2023 | 37022803 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| The Pleiotropic Face of CREB Family Transcription Factors. | Mol Cells | 2023 | 37013623 | PubTator, text mining | PubMed |
| A summary of the current diagnostic methods for, and exploration of the value of microRNAs as biomarkers in, sepsis-associated encephalopathy. | Front Neurosci | 2023 | 37008225 | PubTator, text mining | PubMed |
| SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process. | Front Oncol | 2023 | 37007111 | PubTator, text mining | PubMed |
| Precision targeted therapy for EGFR mutation-positive NSCLC: Dilemmas and coping strategies. | Thorac Cancer | 2023 | 37005552 | PubTator, text mining | PubMed |
| Effects of 5α-dihydrotestosterone on the modulation of monocyte/macrophage response to Staphylococcus aureus: an in vitro study. | Biol Sex Differ | 2023 | 37004108 | PubTator, text mining | PubMed |
| The protease calpain2a limits innate immunity by targeting TRAF6 in teleost fish. | Commun Biol | 2023 | 37002312 | PubTator, text mining | PubMed |
| Human Genome Polymorphisms and Computational Intelligence Approach Revealed a Complex Genomic Signature for COVID-19 Severity in Brazilian Patients. | Viruses | 2023 | 36992353 | PubTator, text mining | PubMed |
| PROTAC'ing oncoproteins: targeted protein degradation for cancer therapy. | Mol Cancer | 2023 | 36991452 | PubTator, text mining | PubMed |
| Chalcones and Gastrointestinal Cancers: Experimental Evidence. | Int J Mol Sci | 2023 | 36983038 | PubTator, text mining | PubMed |
| Immune Regulatory Functions of Macrophages and Microglia in Central Nervous System Diseases. | Int J Mol Sci | 2023 | 36982999 | PubTator, text mining | PubMed |
| Molecular Profiling of Inflammatory Processes in a Mouse Model of IC/BPS: From the Complete Transcriptome to Major Sex-Related Histological Features of the Urinary Bladder. | Int J Mol Sci | 2023 | 36982831 | PubTator, text mining | PubMed |
Salt-Tolerant Plants, Halophytes, as Renewable Natural Resources for Cancer Prevention and Treatment: Roles of Phenolics and Flavonoids in Immunomodulation and Suppression of Oxidative Stress towards Cancer Management. | Int J Mol Sci | 2023 | 36982245 | PubTator, text mining | PubMed |
| Progress toward Better Treatment of Therapy-Related AML. | Cancers (Basel) | 2023 | 36980546 | PubTator, text mining | PubMed |
| Potential Impact of Polymorphisms in Toll-like Receptors 2, 3, 4, 7, 9, miR-146a, miR-155, and miR-196a Genes on Osteoarthritis Susceptibility. | Biology (Basel) | 2023 | 36979150 | PubTator, text mining | PubMed |
| Inflammation Responses to Bone Scaffolds under Mechanical Stimuli in Bone Regeneration. | J Funct Biomater | 2023 | 36976093 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=23